Published in Arch Int Physiol Biochim on December 01, 1976
Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science (1989) 6.67
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature (1993) 3.19
Improved radioimmunoassay for measurement of mouse thyrotropin in serum: strain differences in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone. Thyroid (1999) 2.44
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab (1999) 2.43
Molecular cloning of the thyrotropin receptor. Science (1989) 2.32
Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J Clin Endocrinol Metab (1999) 2.06
RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem Biophys Res Commun (1990) 1.94
Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet (1994) 1.45
Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am J Med (1980) 1.44
Trabecular thyroid adenoma. Am J Surg Pathol (1988) 1.39
The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families. Proc Natl Acad Sci U S A (1996) 1.35
Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with furosemide. N Engl J Med (1981) 1.33
A conserved Asn in transmembrane helix 7 is an on/off switch in the activation of the thyrotropin receptor. J Biol Chem (2001) 1.29
Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med (1998) 1.24
Hypouremia in the syndrome of inappropriate secretion of antidiuretic hormone. Ann Intern Med (1980) 1.23
Effects of morning cortisol elevation on insulin secretion and glucose regulation in humans. Am J Physiol (1996) 1.17
The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol (2003) 1.15
Roles of hydrogen peroxide in thyroid physiology and disease. J Clin Endocrinol Metab (2007) 1.15
Nocturnal decrease in glucose tolerance during constant glucose infusion. J Clin Endocrinol Metab (1989) 1.14
Effects of thyrotropin, prostaglandin E1 and iodide on cyclic 3',5'-AMP concentration in dog thyroid slices. Biochim Biophys Acta (1973) 1.12
Neuroendocrine rhythms and sleep in aging men. Am J Physiol (1991) 1.10
The human thyrotropin receptor activates G-proteins Gs and Gq/11. J Biol Chem (1994) 1.07
Cloning and functional characterization of a human A1 adenosine receptor. Biochem Biophys Res Commun (1992) 1.06
Control of thyroperoxidase and thyroglobulin transcription by cAMP: evidence for distinct regulatory mechanisms. Mol Endocrinol (1989) 1.02
Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab (1996) 1.02
Somatic and germline mutations of the TSH receptor and thyroid diseases. Clin Endocrinol (Oxf) (2001) 1.02
Dual activation by thyrotropin of the phospholipase C and cyclic AMP cascades in human thyroid. Mol Cell Endocrinol (1987) 1.00
Mitogenic effects of thyrotropin and adenosine 3',5'-monophosphate in differentiated normal human thyroid cells in vitro. J Clin Endocrinol Metab (1988) 0.96
TSH Receptor Mutations and Thyroid Disease. Trends Endocrinol Metab (2008) 0.96
Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett (1997) 0.95
Regulation of the release of thyroid hormones: role of cyclic AMP. Ann N Y Acad Sci (1971) 0.94
Urea therapy for inappropriate antidiuretic hormone secretion from tuberculous meningitis. JAMA (1980) 0.93
High uric acid and urea clearance in cirrhosis secondary to increased "effective vascular volume". Am J Med (1982) 0.93
Evidence that cyclic AMP is not the chemical mediator of the metabolic changes accompanying phagocytosis. J Reticuloendothel Soc (1974) 0.92
Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab (1997) 0.90
Decreased basal and stimulated thyrotropin secretion in healthy elderly men. J Clin Endocrinol Metab (1989) 0.90
Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab (1994) 0.90
A population-based health information system. Med Care (1995) 0.89
Hypercalciuria in the syndrome of inappropriate secretion of antidiuretic hormone. Miner Electrolyte Metab (1982) 0.88
Control and role of cyclic 3',5'-guanosine monophosphate. Biochem Biophys Res Commun (1975) 0.88
Effect of ionophore A23187 on thyroid secretion. FEBS Lett (1974) 0.88
Stage-specific adenylate cyclase activity in Trypanosoma brucei. Exp Parasitol (1990) 0.87
Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients. Eur J Endocrinol (2000) 0.87
A mechanism in the control of intracellular cAMP level: the activation of a calmodulin-sensitive phosphodiesterase by a rise of intracellular free calcium. Mol Cell Endocrinol (1985) 0.87
Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity. Endocrinology (2001) 0.87
The relation between adenylate cyclase activation and cAMP acculumation in the horse thyroid gland stimulated by thyrotropin. Mol Cell Endocrinol (1974) 0.86
Absence of human chorionic somatomammotropin during pregnancy associated with two types of gene deletion. Hum Genet (1986) 0.86
Ectopic Cushing's syndrome and pulmonary carcinoid tumour identified by [111In-DTPA-D-Phe1]octreotide. Postgrad Med J (1998) 0.86
Potential role of Noxes in the protection of mucosae: H(2)O(2) as a bacterial repellent. Microbes Infect (2009) 0.85
Multiple G-protein coupling of the dog thyrotropin receptor. Mol Cell Endocrinol (1997) 0.85
[Ischemic pituitary apoplexy and cerebrovascular accident]. Neurochirurgie (1983) 0.84
Inhibition by iodide of the activation of the thyroid cyclic 3',5'-AMP system. Endocrinology (1975) 0.84
Two years of replacement therapy in adults with growth hormone deficiency. Clin Endocrinol (Oxf) (1997) 0.84
Thyroid stimulating immunoglobulins, like thyrotropin activate both the cyclic AMP and the PIP2 cascades in CHO cells expressing the TSH receptor. Mol Cell Endocrinol (1992) 0.83
Cell biology of H2O2 generation in the thyroid: investigation of the control of dual oxidases (DUOX) activity in intact ex vivo thyroid tissue and cell lines. Mol Cell Endocrinol (2011) 0.83
Cyclic nucleotide hydrolysis in the thyroid gland. General properties and key role in the interrelations between concentrations of adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate. Eur J Biochem (1977) 0.83
Pathogenesis of autonomous thyroid nodules: in vitro study of iodine and adenosine 3',5'-monophosphate metabolism. J Clin Endocrinol Metab (1988) 0.83
Autonomy in endemic goiter. Thyroid (1998) 0.82
Structure-function relationships of two loss-of-function mutations of the thyrotropin receptor gene. Thyroid (1999) 0.82
Transcriptional control of thyroglobulin gene expression by cyclic AMP. FEBS Lett (1985) 0.82
Argyrophilic breast carcinoma, single metastasis to the pituitary gland. Bull Cancer (1990) 0.82
Sphingolipid-cholesterol domains (lipid rafts) in normal human and dog thyroid follicular cells are not involved in thyrotropin receptor signaling. Endocrinology (2003) 0.82
Enhancement of endothelial cAMP accumulation by adenine nucleotides: role of methylxanthine-sensitive sites. Am J Physiol (1993) 0.82
Carbachol and sodium fluoride, but not TSH, stimulate the generation of inositol phosphates in the dog thyroid. FEBS Lett (1987) 0.82
Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene. J Clin Endocrinol Metab (1997) 0.82
Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population. Eur J Endocrinol (2002) 0.81
In vitro nonbutanol-extractable iodine release in dog thyroid. Endocrinology (1979) 0.81
Inhibition by iodide of iodide binding to proteins: the "Wolff-Chaikoff" effect is caused by inhibition of H2O2 generation. Biochem Biophys Res Commun (1988) 0.81
Tumor promoters as probes of protein kinase C in dog thyroid cell: inhibition of the primary effects of carbamylocholine and reproduction of some distal effects. Metabolism (1987) 0.81
Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology. Thyroid (2000) 0.81
Negative control of TSH action by iodide and acetylcholine: mechanism of action in intact thyroid cells. J Cyclic Nucleotide Res (1977) 0.81
TSH receptor and disease. Clin Endocrinol (Oxf) (1996) 0.81
Pathology of the TSH receptor. J Pediatr Endocrinol Metab (1999) 0.81
Stimulation of generation of inositol phosphates by carbamoylcholine and its inhibition by phorbol esters and iodide in dog thyroid cells. Biochem J (1989) 0.81
Mechanism of estrogen action--independence of several responses of the rat uterus from the early increase in adenosine 3',5'-cyclic monophosphate. J Steroid Biochem (1974) 0.81
Kinetics of dog thyroid secretion in vitro. Endocrinology (1978) 0.81
Kinetics of adenosine 3':5'-monophosphate accumulation in dog thyroid slices. Eur J Biochem (1976) 0.81
Constitutively active receptors as a disease-causing mechanism. Mol Cell Endocrinol (1994) 0.81
H2 receptor-mediated responses of aortic endothelial cells to histamine. Am J Physiol (1992) 0.81
Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices. J Clin Invest (1991) 0.80
Impaired counterregulation of glucose in a patient with hypothalamic sarcoidosis. N Engl J Med (1999) 0.80
Stimulation by forskolin of the thyroid adenylate cyclase, cyclic AMP accumulation and iodine metabolism. Mol Cell Endocrinol (1983) 0.80
Expression of multiple adenylyl cyclase isoforms in human and dog thyroid. Mol Cell Endocrinol (2000) 0.80
Acrylamide, an in vivo thyroid carcinogenic agent, induces DNA damage in rat thyroid cell lines and primary cultures. Mol Cell Endocrinol (2006) 0.80
Species specific thyroid signal transduction: conserved physiology, divergent mechanisms. Mol Cell Endocrinol (2010) 0.80
Biosynthesis and metabolism of 2-iodohexadecanal in cultured dog thyroid cells. J Biol Chem (1996) 0.79